VNDA: 万达生物制药

VNDA新闻

• 12:35 Intellia Therapeutics (NTLA) Surges 6.3%: Is This an Indication of Further Gains?
• 22:26 Vanda Pharmaceuticals Inc. (VNDA) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
• 14:55 Vanda (VNDA) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now
• 09:55 Royalty Pharma and Teva’s $500 million IL-15 deal boosts AnaptysBio stock
• 00:25 Anaptysbio (ANAB) chief medical officer sells $163,191 in stock
• 03:14 Anaptysbio首席财务官Mulroy出售价值8.6万美元股票
• 03:13 Anaptysbio CFO Mulroy sells $86k in shares
• 02:54 AnaptysBio首席医疗官Lizzul出售价值10万美元公司股票
• 02:53 AnaptysBio CMO Lizzul sells $100k in stock
• 12:17 Vanda制药公司股票在FDA拒绝时差治疗申请后下跌
• 12:13 Vanda Pharmaceuticals stock falls after FDA rejects jet lag treatment application
• 12:05 FDA rejects Vanda’s jet lag treatment application
• 08:06 Immuneering, Phathom Pharmaceuticals, Canadian Solar And Other Big Stocks Moving Lower In Thursday's Pre-Market Session - Canadian Solar (NASDAQ:CSIQ), Elme (NYSE:ELME)
• 06:31 UBS以买入评级和70美元目标价启动对AnaptysBio股票的覆盖
• 06:29 AnaptysBio stock rating initiated at Buy by UBS with $70 price target
• 02:17 Anaptysbio首席执行官Faga出售价值66.2万美元股票
• 02:16 Anaptysbio CEO Faga sells $662k in shares
• 02:16 Anaptysbio CFO Mulroy sells $145k in shares
• 02:12 Anaptysbio CLO Eric Loumeau sells $129k in shares
• 13:32 FDA Approves Vanda Pharma Motion Sickness Drug, Fuels Upside - Vanda Pharmaceuticals (NASDAQ:VNDA)
• 12:32 万达制药股票目标价被H.C. Wainwright上调至22美元
• 12:31 Vanda Pharmaceuticals stock price target raised to $22 by H.C. Wainwright
• 18:28 Vanda Pharmaceuticals: SG&A Takes Off, TAM Doesn’t (Rating Downgrade) (VNDA)
• 12:40 Vanda's 2026 Catalyst Run With Nereus Launch And Bysanti PDUFA In Focus (NASDAQ:VNDA)